ArticleScientific reports2019

Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts.

Jennifer L Leiting et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.